Board of Commissioners

Dr. Maureen Doyle-Scharff, PhD, MBA, FACEHP, is a visionary change agent who is an expert in brokering public-private partnerships that drive changes in the global healthcare ecosystem. Recently retired from Pfizer Inc, she spent nearly 25 years leading a cross-functional global team focused on enabling healthcare communities to advance science and close gaps in care through independent and collaborative grants and partnerships. In addition, she spent the last few years leading Pfizer’s Institute of Translational Equitable Medicine (ITEM), focused on the science behind health disparities and translating new data and information to improve patient outcomes globally.She has worked in the fields of medical and pharmacy education, continuing professional development, grants, quality improvement and behavior/systems change in a variety of capacities for over 30 years. Her global experience affords her a deep understanding and appreciation of the differences across countries and regions in terms of accreditation, credentialling and certification. Her passion and current work focus on empowering health equity through education and innovation; bridging care gaps with evidence-based approaches; and driving sustainable change via collaborative partnerships.Active in the CME, CE and CPD communities around the world, Maureen has served as President of the Global Alliance for Medical Education (GAME), President of the Commission for the Certification of Healthcare CPD Professionals (CCHCP), is a former member of the AMA National Task Force on Provider/Industry CME Relationships, is founder and past president of the Ohio Chapter of the Healthcare Businesswomen's Association, and served for six years on the Board of Directors for the Alliance for Continuing Education in the Health Professions (ACEHP).Maureen received her undergraduate degree from the University of Michigan, her MBA from St. Joseph University, and her PhD in Higher Education Leadership from Ohio University.

‍